Small, sharp, studied for calming inflammatory signalling.
KPV is a C-terminal tripeptide fragment of alpha-MSH studied for its selective engagement of melanocortin receptor pathways. Research suggests it may downregulate NF-κB-mediated pro-inflammatory signaling while leaving broader immune surveillance pathways intact. Preclinical data indicates potential interaction with intestinal epithelial barrier function and cytokine regulation. Intended for research purposes.


KPV is a C-terminal tripeptide fragment of alpha-MSH studied for its selective engagement of melanocortin receptor pathways. Research suggests it may down-regulate NF-κB-driven inflammatory signaling while leaving broader immune surveillance intact — a distinction researchers highlight when comparing it to less selective anti-inflammatory approaches.
Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.